Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
April 16, 2024 04:35 ET
|
Boehringer Ingelheim
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8...
Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers
April 11, 2024 08:05 ET
|
Tevogen Bio Inc
Tevogen’s Chief Scientific Officer explains the company’s oncology pipeline strategy as it relates to harnessing Cytotoxic T Lymphocytes to target cancers.
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
April 09, 2024 16:00 ET
|
Mural Oncology, Inc.
Mural Oncology, a clinical-stage immuno-oncology company, shared pre-clinical data from its Interleukin-18 (IL-18) and IL-12 programs at AACR today.
Aegion Announces Acquisition of Toncco
March 27, 2024 11:00 ET
|
Aegion Corp
Aegion Corporation today announced the acquisition of Toncco, an underground utilities company based in Ogden, Utah.
CarbonMeta Technologies Wins Sole Source Contract with Saudi Investment Recycling Company (SIRC)
February 20, 2024 08:30 ET
|
CarbonMeta Technologies, Inc.
CarbonMeta and SIRC to launch cement-less concrete pilot project in March 2024 Riyadh, Saudi Arabia and Woodinville, WA, USA, Feb. 20, 2024 (GLOBE NEWSWIRE) -- CarbonMeta Technologies Inc. (OTC...
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024 08:30 ET
|
BioSig Technologies, Inc.
Cost Savings Targeted to Reduce Cash Burn by 50% Core Strategy Shifts to Business Development and Distribution Partnerships Westport, CT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- BioSig...
Boehringer expands production site in Greece for new medicine
January 11, 2024 10:15 ET
|
Boehringer Ingelheim
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the...
Mural Oncology Announces Enhancements to Late-Stage Clinical Trials
January 08, 2024 07:00 ET
|
Mural Oncology, Inc.
Strategic changes to ARTISTRY-6 and ARTISTRY-7, both potentially registrational trials of nemvaleukin, are intended to result in more clinically meaningful dataMural intends to nominate development...
Canadian Shade: Providing Top-of-the-Line Shade Solutions for the Whole Family
December 19, 2023 14:00 ET
|
Canadian Shade Inc.
As winter approaches and temperatures drop in Toronto, Canadian Shade is extending its commitment to the community in a heartwarming initiative.
EVerZom: Therapeutic Ambition in Exosome Biotherapies
December 13, 2023 05:07 ET
|
Everzom
EVerZom: Therapeutic Ambition in Exosome Biotherapies EVerZom, winner of the EIC Accelerator for its breakthrough technology platform, presents its proprietary pipeline of exosome-based...